Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 54

1.

Comment on: The incidence and risk factors of metastasis for cutaneous squamous cell carcinoma-implications on the T-classification system.

Jambusaria-Pahlajani A, Karia PS, Parker AS, Schmults CD.

J Surg Oncol. 2014 Dec 9. doi: 10.1002/jso.23841. [Epub ahead of print] No abstract available.

PMID:
25492622
[PubMed - as supplied by publisher]
2.

Loss of PBRM1 and BAP1 expression is less common in non-clear cell renal cell carcinoma than in clear cell renal cell carcinoma.

Ho TH, Kapur P, Joseph RW, Serie DJ, Eckel-Passow JE, Parasramka M, Cheville JC, Wu KJ, Frenkel E, Rakheja D, Stefanius K, Brugarolas J, Parker AS.

Urol Oncol. 2014 Nov 24. pii: S1078-1439(14)00357-3. doi: 10.1016/j.urolonc.2014.10.014. [Epub ahead of print]

PMID:
25465300
[PubMed - as supplied by publisher]
3.

Mayo Adhesive Probability Score: An Accurate Image-based Scoring System to Predict Adherent Perinephric Fat in Partial Nephrectomy.

Davidiuk AJ, Parker AS, Thomas CS, Leibovich BC, Castle EP, Heckman MG, Custer K, Thiel DD.

Eur Urol. 2014 Dec;66(6):1165-71. doi: 10.1016/j.eururo.2014.08.054. Epub 2014 Sep 2.

PMID:
25192968
[PubMed - in process]
4.

Assessing the clinical use of clear cell renal cell carcinoma molecular subtypes identified by RNA expression analysis.

Eckel-Passow JE, Igel DA, Serie DJ, Joseph RW, Ho TH, Cheville JC, Parker AS.

Urol Oncol. 2014 Aug 27. pii: S1078-1439(14)00276-2. doi: 10.1016/j.urolonc.2014.07.019. [Epub ahead of print]

PMID:
25175426
[PubMed - as supplied by publisher]
5.

Baseline and follow-up association of the MAX-PC in Men with newly diagnosed prostate cancer.

Tavlarides AM, Ames SC, Thiel DD, Diehl NN, Parker AS.

Psychooncology. 2014 Jun 21. doi: 10.1002/pon.3605. [Epub ahead of print]

PMID:
24953309
[PubMed - as supplied by publisher]
6.

Genomic medicine and incidental findings: balancing actionability and patient autonomy.

McCormick JB, Sharp RR, Farrugia G, Lindor NM, Babovic-Vuksanovic D, Borad MJ, Bryce AH, Caselli RJ, Ferber MJ, Johnson KJ, Lazaridis KN, McWilliams RR, Murray JA, Parker AS, Schahl KA, Wieben ED.

Mayo Clin Proc. 2014 Jun;89(6):718-21. doi: 10.1016/j.mayocp.2014.04.008. No abstract available.

PMID:
24943691
[PubMed - indexed for MEDLINE]
7.

External validation of a multiplex urinary protein panel for the detection of bladder cancer in a multicenter cohort.

Chen LM, Chang M, Dai Y, Chai KX, Dyrskj√łt L, Sanchez-Carbayo M, Szarvas T, Zwarthoff EC, Lokeshwar V, Jeronimo C, Parker AS, Ross S, Borre M, Orntoft TF, Jaeger T, Beukers W, Lopez LE, Henrique R, Young PR, Urquidi V, Goodison S, Rosser CJ.

Cancer Epidemiol Biomarkers Prev. 2014 Sep;23(9):1804-12. doi: 10.1158/1055-9965.EPI-14-0029. Epub 2014 Jun 11.

PMID:
24920641
[PubMed - in process]
8.

Intravesical ALT-803 and BCG treatment reduces tumor burden in a carcinogen induced bladder cancer rat model; a role for cytokine production and NK cell expansion.

Gomes-Giacoia E, Miyake M, Goodison S, Sriharan A, Zhang G, You L, Egan JO, Rhode PR, Parker AS, Chai KX, Wong HC, Rosser CJ.

PLoS One. 2014 Jun 4;9(6):e96705. doi: 10.1371/journal.pone.0096705. eCollection 2014.

PMID:
24896845
[PubMed - in process]
Free PMC Article
9.

Re: Samira A. Brooks, A. Rose Brannon, Joel S. Parker, et al. ClearCode34: A Prognostic Risk Predictor for Localized Clear Cell Renal Cell Carcinoma. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2014.02.035.

Parker AS, Leibovich BC, Eckel-Passow JE, Cheville JC.

Eur Urol. 2014 May 27. pii: S0302-2838(14)00419-9. doi: 10.1016/j.eururo.2014.05.009. [Epub ahead of print] No abstract available.

PMID:
24877662
[PubMed - as supplied by publisher]
10.

ANKS1B is a smoking-related molecular alteration in clear cell renal cell carcinoma.

Eckel-Passow JE, Serie DJ, Bot BM, Joseph RW, Cheville JC, Parker AS.

BMC Urol. 2014 Jan 31;14:14. doi: 10.1186/1471-2490-14-14.

PMID:
24479813
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Higher Expression of Topoisomerase II Alpha Is an Independent Marker of Increased Risk of Cancer-specific Death in Patients with Clear Cell Renal Cell Carcinoma.

Parker AS, Eckel-Passow JE, Serie D, Hilton T, Parasramka M, Joseph RW, Wu KJ, Cheville JC, Leibovich BC.

Eur Urol. 2013 Dec 25. pii: S0302-2838(13)01365-1. doi: 10.1016/j.eururo.2013.12.017. [Epub ahead of print]

PMID:
24388441
[PubMed - as supplied by publisher]
12.

Somatic expression of ENRAGE is associated with obesity status among patients with clear cell renal cell carcinoma.

Eckel-Passow JE, Serie DJ, Bot BM, Joseph RW, Hart SN, Cheville JC, Parker AS.

Carcinogenesis. 2014 Apr;35(4):822-7. doi: 10.1093/carcin/bgt485. Epub 2013 Dec 28.

PMID:
24374825
[PubMed - indexed for MEDLINE]
13.

Evaluation of awareness of risk factors for kidney cancer among patients presenting to a urology clinic.

Parker AS, Arnold ML, Diehl ND, Hassan L, Thiel DD.

Scand J Urol. 2014 Jun;48(3):239-44. doi: 10.3109/21681805.2013.863803. Epub 2013 Dec 12.

PMID:
24328689
[PubMed - in process]
14.

Comparison of baseline quality of life measures between renal cell carcinoma patients undergoing partial versus radical nephrectomy.

Arnold ML, Thiel DD, Diehl N, Wu KJ, Ames S, Parker AS.

BMC Urol. 2013 Oct 22;13:52. doi: 10.1186/1471-2490-13-52.

PMID:
24148752
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Lack of Association between COX-2 Staining Level and Biochemical Recurrence Following Salvage Radiation Therapy for Recurrent Prostate Cancer.

Heckman MG, Tzou KS, Parker AS, Pisansky TM, Schild SE, Hilton TW, Patel VN, Pelaez L, Khor LY, Peterson JL, Daugherty LC, Vallow LA, Pollack A, Buskirk SJ.

J Radiat Oncol. 2013 Sep 1;2(3):309-314.

PMID:
24073305
[PubMed]
Free PMC Article
16.

Maximum tumor diameter is not an accurate predictor of renal cell carcinoma tumor volume.

Thiel DD, Jorns J, Lohse CM, Cheville JC, Thompson RH, Parker AS.

Scand J Urol. 2013 Dec;47(6):472-5. doi: 10.3109/21681805.2013.814071. Epub 2013 Jul 24.

PMID:
23883351
[PubMed - indexed for MEDLINE]
17.

Age-period-cohort analysis of renal cell carcinoma in United States adults.

Tyson MD, Humphreys MR, Parker AS, Thiel DD, Joseph RW, Andrews PE, Castle EP.

Urology. 2013 Jul;82(1):43-7. doi: 10.1016/j.urology.2013.02.065. Epub 2013 May 22.

PMID:
23706585
[PubMed - indexed for MEDLINE]
18.

Evaluation of Serum Calcium as a Predictor of Biochemical Recurrence following Salvage Radiation Therapy for Prostate Cancer.

Peterson JL, Buskirk SJ, Heckman MG, Parker AS, Diehl NN, Tzou KS, Paryani NN, Ko SJ, Daugherty LC, Vallow LA, Pisansky TM.

ISRN Oncol. 2013 Mar 31;2013:239241. doi: 10.1155/2013/239241. Print 2013.

PMID:
23606986
[PubMed]
Free PMC Article
19.

Impact of fellowship training on one-year outcomes of robotic-assisted prostatectomy.

Thiel DD, Hutchinson R, Diehl N, Tavlarides A, Williams A, Parker AS.

JSLS. 2012 Apr-Jun;16(2):195-201.

PMID:
23477165
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Cost analysis of open radical cystectomy versus robot-assisted radical cystectomy.

Mmeje CO, Martin AD, Nunez-Nateras R, Parker AS, Thiel DD, Castle EP.

Curr Urol Rep. 2013 Feb;14(1):26-31. doi: 10.1007/s11934-012-0292-7. Review.

PMID:
23184624
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk